about
Insulin versus oral agents in the management of Cystic Fibrosis Related Diabetes: a case based study.CFTR is involved in the regulation of glucagon secretion in human and rodent alpha cells.Impaired fasting glucose in cystic fibrosisEpidemiology, pathophysiology, and prognostic implications of cystic fibrosis-related diabetes: a technical review.Diagnosis and treatment of endocrine comorbidities in patients with cystic fibrosis.Quantifying insulin sensitivity and entero-insular responsiveness to hyper- and hypoglycemia in ferretsSex-specific effect of estrogen sulfotransferase on mouse models of type 2 diabetesInsulin secretion abnormalities in exocrine pancreatic sufficient cystic fibrosis patients.Abnormal endocrine pancreas function at birth in cystic fibrosis ferrets.Early Alterations in Glycemic Control and Pancreatic Endocrine Function in Nondiabetic Patients With Chronic PancreatitisA Transient Metabolic Recovery from Early Life Glucose Intolerance in Cystic Fibrosis Ferrets Occurs During Pancreatic RemodelingThe ΔF508 Mutation in the Cystic Fibrosis Transmembrane Conductance Regulator Is Associated With Progressive Insulin Resistance and Decreased Functional β-Cell Mass in Mice.Cystic fibrosis-related diabetes: from CFTR dysfunction to oxidative stress.Pharmacotherapy of diabetes in cystic fibrosis patients.CF-related diabetes: Containing the metabolic miscreant of cystic fibrosis.CFTR silencing in pancreatic β-cells reveals a functional impact on glucose-stimulated insulin secretion and oxidative stress response.Diagnosing cystic fibrosis-related diabetes: current methods and challenges.Mechanisms of insulin resistance in cystic fibrosis.Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction.Reduced β-Cell Secretory Capacity in Pancreatic-Insufficient, but Not Pancreatic-Sufficient, Cystic Fibrosis Despite Normal Glucose Tolerance.Pancreatic and Islet Remodeling in Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Knockout Ferrets.Decreased insulin secretion and glucose clearance in exocrine pancreas-insufficient pigs.Understanding cystic-fibrosis-related diabetes: best thought of as insulin deficiency?Evolving Mechanistic Views and Emerging Therapeutic Strategies for Cystic Fibrosis-Related Diabetes.An Increase in Chromogranin A-Positive, Hormone-Negative Endocrine Cells in Pancreas in Cystic Fibrosis
P2860
Q33247492-91710CF9-B4CB-4711-B1F2-C9E025148F3CQ33671461-B2AEAE8C-4C6F-4EEA-AFD8-94FD27CCF2D1Q34351881-242F47B6-7E9F-4C7A-84C4-6B2070911774Q34351912-F323DD72-01EE-4339-ABF2-F59F28BB8E1DQ35077819-180EE53F-12FF-499A-AABF-2380A275F69DQ35110731-74769F50-AAC5-4499-BC34-B9AF0636F87CQ35976730-0494F439-B2A2-4E8B-ABFC-EC6FCE7F7CAEQ36031080-A9A95C86-94A8-4CCF-B2B4-68FA18153589Q36499679-F1B18B42-5F51-4BED-8510-7A280FACC489Q36664923-D9C2DB28-7036-4840-84D8-3C0D0C0ED3F9Q36911550-CB8C9780-2A9E-437A-AAED-CBBA2F713B1DQ36926385-90B26578-CB32-4631-A94D-391D6129A5D4Q37470271-2C193361-6A64-4DAE-B490-51650C8ABBAEQ37694561-E35E550D-E06A-4733-BD59-BE4C560FE80AQ38656600-70550CC2-5847-4B58-A163-B19D9DFDF3F7Q38815266-0008A030-D696-4050-A275-504696BB2A66Q38857042-F95B3613-34B7-4365-AB43-6149DB48B84CQ43762952-8E927F52-03C6-44E9-BBB4-13C4D3AEB854Q43965908-62D674BD-612C-44F0-8D17-662671DD056FQ47158498-92282172-AED7-41B6-9EFF-68A15CC5A51FQ49795312-78AA8EF9-7FDD-46F4-8664-04D583F769FCQ51292778-ADB1A6BC-235B-44B8-8888-A9CA6B57CDFFQ51529221-7E234F10-3114-4AF3-BC83-EFF6C314B2C8Q52739000-D7D3CE6A-AC8C-4735-A173-79792A5B0BCBQ58784432-CAB600BF-DCA7-4099-BEDC-0F5B75DE22C6
P2860
description
1994 nî lūn-bûn
@nan
1994 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1994 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
name
Insulin sensitivity in cystic fibrosis.
@ast
Insulin sensitivity in cystic fibrosis.
@en
Insulin sensitivity in cystic fibrosis.
@nl
type
label
Insulin sensitivity in cystic fibrosis.
@ast
Insulin sensitivity in cystic fibrosis.
@en
Insulin sensitivity in cystic fibrosis.
@nl
prefLabel
Insulin sensitivity in cystic fibrosis.
@ast
Insulin sensitivity in cystic fibrosis.
@en
Insulin sensitivity in cystic fibrosis.
@nl
P2093
P356
P1433
P1476
Insulin sensitivity in cystic fibrosis.
@en
P2093
Pyzdrowski KL
Seaquist ER
P304
P356
10.2337/DIAB.43.8.1020
P407
P577
1994-08-01T00:00:00Z